Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Mar 2023
The American College of Rheumatology (ACR) and the American College of Hip Surgery (AAHKS) have released new guidelines.
Read Full NewsPain that interferes with daily functioning is associated with higher odds of frailty and its progression in adult survivors of childhood cancer.
Cancer care is becoming too complex for any one clinician to track alone, making AI an increasingly valuable tool in modern oncology.
New data with longer-term follow-up suggest that PSA screening probably lowers prostate cancer mortality — but experts stress the gains are modest and come with risk for overdiagnosis.
The CAPItello-281 trial reported a 19% improvement in radiographic progression-free survival.
1.
Mindfulness-based interventions are advised by cancer organizations to treat patients' anxiety and depression.
2.
Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy
3.
Alternative breast imaging techniques beyond mammography.
4.
EBV Screening Tied to Lower Nasopharyngeal Cancer Mortality Risk
5.
GLP-1 drugs linked to dramatically lower death rates in colon cancer patients
1.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
2.
Respiratory Ramifications of Systemic Disease: A Comprehensive Review
3.
Revolutionizing Cancer Treatment with Mercaptopurine: A New Hope for Patients
4.
Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care
5.
The Truth About Marijuana and Its Effect on Mental Health
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
5.
Should We Use DARA Up Front As First-Line Therapy in MM?
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge